Why participate?
Present new therapeutic approaches using biopharmaceuticals in immuno-oncology, along with their advantages and limitations
Training Context:
Immuno-oncology is a rapidly expanding field. The therapeutic successes of antibodies (via immune checkpoint inhibitors) and CAR T-cells have opened a new chapter in medicine. The goal is no longer to target the cancer itself, but to target the immune system—training it to specifically recognize and fight the patient’s tumor.
This training, delivered in 2021 as part of the “MabDesign Academy” program, offers a high level of expertise.
Interactive Teaching, Case Studies, Experience Sharing
All scientific audiences: R&D managers, project leaders, academic researchers, engineers, technicians, CSOs-CEOs
Solid knowledge of biology and biotechnology, or completion of the “Fundamentals of Immuno-Oncology” training
Only available as in-house training
Prices: Excluding tax, as the training is not subject to VAT.
In-house training rate: Please contact us.
There is no rating available because this training session was never carried out.
Registering online or by e-mail is a pre-registration. We will process your request within one week:
Signing the training agreement commits the company or individual to the training course. Cancellation conditions are specified in the training agreement.
When no session date is specified, pre-registration allows us to note your interest in a programme, and we will keep you informed as soon as a new session is organised.
For more information, contact Daphné Brisard: 02 47 36 63 18 or formation@mabdesign.fr
